BLUEBIRD BIO, INC. — TTAB Proceedings
BLUEBIRD BIO, INC. is a party to 4 TTAB proceedings.
Proceedings
- Proceeding 92083399 — Cancellations, Terminated (filed 2023-10-04) against Hikma Pharmaceuticals USA Inc. as defendant
- Proceeding 79302887 — Extensions of Time to Oppose, Terminated (filed 2021-12-07) against Spark Therapeutics, Inc. as defendant
- Proceeding 91270249 — Oppositions, Terminated (filed 2021-06-30) against Spark Therapeutics, Inc. as defendant
- Proceeding 88244187 — Extensions of Time to Oppose, Terminated (filed 2019-12-10) against UPMC as plaintiff
Marks in These TTAB Matters
- STARGENSA — proceeding 92083399 (Defendant)
- SPARK CHANGE — proceeding 79302887 (Defendant)
- I AM THE SPARK — proceeding 91270249 (Defendant)
Common TTAB Counterparties
- Spark Therapeutics, Inc. — 2 proceedings
- Hikma Pharmaceuticals USA Inc. — 1 proceedings
- UPMC — 1 proceedings
Recent TTAB Timeline
- 2024-03-07: 92083399 — COMMR ORDER CANCELLING REG involving Hikma Pharmaceuticals USA Inc.
- 2024-03-07: 92083399 — COMMR ORDER CANCELLING REG involving Hikma Pharmaceuticals USA Inc.
- 2024-03-07: 92083399 — TERMINATED involving Hikma Pharmaceuticals USA Inc.
- 2024-03-07: 92083399 — COMMR ORDER CANCELLING REG involving Hikma Pharmaceuticals USA Inc.
- 2024-03-06: 92083399 — REFUND ISSUED - TRADEMARK RULE 2.114(A)(2) involving Hikma Pharmaceuticals USA Inc.
- 2024-03-06: 92083399 — REFUND IN PROCESS - TRADEMARK RULE 2.114(A)(2) involving Hikma Pharmaceuticals USA Inc.
- 2024-01-13: 92083399 — BOARD'S DECISION: GRANTED involving Hikma Pharmaceuticals USA Inc.
- 2023-11-30: 92083399 — NOTICE OF DEFAULT involving Hikma Pharmaceuticals USA Inc.
- 2023-10-11: 92083399 — PENDING, INSTITUTED involving Hikma Pharmaceuticals USA Inc.
- 2023-10-11: 92083399 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Hikma Pharmaceuticals USA Inc.
- 2023-10-04: 92083399 — FILED AND FEE involving Hikma Pharmaceuticals USA Inc.
- 2022-04-01: 79302887 — EXTENSION OF TIME GRANTED involving Spark Therapeutics, Inc.
- 2022-04-01: 79302887 — FINAL 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Spark Therapeutics, Inc.
- 2021-12-07: 79302887 — EXTENSION OF TIME GRANTED involving Spark Therapeutics, Inc.
- 2021-12-07: 79302887 — FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE involving Spark Therapeutics, Inc.
- 2021-11-22: 91270249 — TERMINATED involving Spark Therapeutics, Inc.
- 2021-11-22: 91270249 — BD'S DECISION: DISMISSED W/O PREJUDICE involving Spark Therapeutics, Inc.
- 2021-10-12: 91270249 — WITHDRAWAL OF APPLICATION involving Spark Therapeutics, Inc.
- 2021-09-28: 91270249 — MOT TO AMEND APPLICATION involving Spark Therapeutics, Inc.
- 2021-09-10: 91270249 — ANSWER involving Spark Therapeutics, Inc.
- 2021-09-07: 91270249 — D APPEARANCE / POWER OF ATTORNEY involving Spark Therapeutics, Inc.
- 2021-08-05: 91270249 — EXTENSION OF TIME GRANTED involving Spark Therapeutics, Inc.
- 2021-08-05: 91270249 — D'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Spark Therapeutics, Inc.
- 2021-07-02: 91270249 — PENDING, INSTITUTED involving Spark Therapeutics, Inc.
- 2021-07-02: 91270249 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Spark Therapeutics, Inc.
- 2021-06-30: 91270249 — FILED AND FEE involving Spark Therapeutics, Inc.
- 2020-01-23: 88244187 — TERMINATED involving UPMC
- 2019-12-10: 88244187 — EXTENSION OF TIME GRANTED involving UPMC
- 2019-12-10: 88244187 — FIRST 30-DAY REQUEST TO EXT TIME TO OPPOSE involving UPMC